J. J. Walker, F. Spiga, E. Waite, Z. Zhao, Y. Kershaw et al., The origin of glucocorticoid hormone oscillations Individual variation in glucocorticoid stress responses in animals Molecular mechanisms and cellular effects of glucocorticosteroids, PLoS Biol General and Comparative Endocrinology General and Comparative Endocrinology Immunol Allergy Clin North Am, vol.104, issue.25, pp.45-58, 2002.

J. J. Logie, S. A. Kathryn, M. Marshall, M. M. Heck, B. R. Walker et al., Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration Public Library of Science On the retinal toxicity of intraocular glucocorticoids The glucocorticoid receptor: pivot of depression and of antidepressant treatment, Biochem Pharmacol Psychoneuroendocrinology, vol.57, issue.36, pp.1878-86, 2010.

H. Schacke, W. D. Docke, K. Asadullah, J. Folkman, D. E. Ingber et al., Mechanisms involved in the side effects of glucocorticoids, Pharmacology & Therapeutics, vol.96, issue.1, pp.23-43, 1983.
DOI : 10.1016/S0163-7258(02)00297-8

G. R. Small, P. W. Hadoke, I. Sharif, A. R. Dover, D. Armour et al., Preventing local regeneration of glucocorticoids by 11??-hydroxysteroid dehydrogenase type 1 enhances angiogenesis, Proceedings of the National Academy of Sciences, vol.102, issue.34, pp.12165-70, 2005.
DOI : 10.1073/pnas.0500641102

E. A. Shikatani, Inhibition of Proliferation, Migration and Proteolysis Contribute to Corticosterone-Mediated Inhibition of Angiogenesis, PLoS ONE, vol.7, issue.10, p.46625, 2012.
DOI : 10.1371/journal.pone.0046625.s002

M. Schmidt, H. G. Pauels, N. Lugering, A. Lugering, W. Domschke et al., Glucocorticoids induce apoptosis in human monocytes: potential role of IL- 1 beta, J Immunol, vol.163, pp.3484-90, 1999.

A. Sharma, A. Pirouzmanesh, J. Patil, M. F. Estrago-franco, L. C. Zacharias et al., Evaluation of the Toxicity of Triamcinolone Acetonide and Dexamethasone Sodium Phosphate on Human Lens Epithelial Cells (HLE B-3), Journal of Ocular Pharmacology and Therapeutics, vol.27, issue.3, pp.265-71, 2011.
DOI : 10.1089/jop.2010.0120

A. Katychev, X. Wang, A. Duffy, and P. Dore-duffy, Glucocorticoid-Induced Apoptosis in CNS Microvascular Pericytes, Developmental Neuroscience, vol.25, issue.6, pp.436-482, 2003.
DOI : 10.1159/000075669

D. B. Allen, L. Bielory, H. Derendorf, R. Dluhy, G. L. Colice et al., Inhaled Corticosteroids, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.1-40, 2003.
DOI : 10.1016/S0091-6749(03)01859-1

Z. M. Hu, H. B. Wang, M. Q. Zhou, X. S. Yao, L. Ma et al., [Pathological changes of the blood vessels in rabbit femoral head with glucocorticoidinduced necrosis], Nan Fang Yi Ke Da Xue Xue Bao, vol.26, pp.785-792, 2006.

F. Behar-cohen, Cibles r??tiniennes d???action des m??dicaments, Annales Pharmaceutiques Fran??aises, vol.69, issue.2, pp.124-154, 2011.
DOI : 10.1016/j.pharma.2011.01.003

N. Miyamoto, D. Iossifov, F. Metge, and F. Behar-cohen, Early Effects of Intravitreal Triamcinolone on Macular Edema, Ophthalmology, vol.113, issue.11, pp.2048-53, 2006.
DOI : 10.1016/j.ophtha.2006.05.037

F. Valamanesh, Effects of triamcinolone acetonide on vessels of the posterior segment of the eye, Mol Vis, vol.15, pp.2634-2682, 2009.

M. E. Hartnett, D. J. Martiniuk, Y. Saito, P. Geisen, L. J. Peterson et al., Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy, Investigative Opthalmology & Visual Science, vol.47, issue.11, pp.4975-82, 2006.
DOI : 10.1167/iovs.06-0450

P. Corvol and N. Vinay, ?? L???arbre vasculaire, les nouvelles voies de la gu??rison ??, Revue des Maladies Respiratoires, vol.26, issue.9, 2008.
DOI : 10.1016/S0761-8425(09)73343-1

A. Geltzer, A. Turalba, and S. S. Vedula, Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration, Cochrane Database Syst Rev, vol.1, p.5022, 2013.

C. K. Chan, M. S. Ip, P. C. Vanveldhuisen, N. L. Oden, I. U. Scott et al., SCORE Study Report #11, Ophthalmology, vol.118, pp.1364-72, 2011.
DOI : 10.1016/j.ophtha.2010.11.020

URL : http://doi.org/10.1016/j.ophtha.2010.11.020

L. Galluzzi, Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Cell Death and Differentiation, vol.94, issue.1, pp.107-127, 2012.
DOI : 10.1083/jcb.200712051

E. W. Ades, F. J. Candal, R. A. Swerlick, V. G. George, S. Summers et al., HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line, Journal of Investigative Dermatology, vol.99, issue.6, pp.683-90, 1992.
DOI : 10.1111/1523-1747.ep12613748

A. Capetandes and M. E. Gerritsen, Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes, Invest Ophthalmol Vis Sci, vol.31, pp.1738-1782, 1990.

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

N. Zhua and Z. W. , An Assay for DNA Fragmentation in Apoptosis without Phenol/Chloroform Extraction and Ethanol Precipitation, Analytical Biochemistry, vol.246, issue.1, pp.155-158, 1997.
DOI : 10.1006/abio.1997.2018

S. Altairac, S. Zeggai, P. Perani, Y. Courtois, and A. Torriglia, Apoptosis induced by Na+/H+ antiport inhibition activates the LEI/L-DNase II pathway, Cell Death and Differentiation, vol.10, issue.5, pp.548-57, 2003.
DOI : 10.1038/sj.cdd.4401195

A. Torriglia, E. Chaudun, F. Chany-fournier, J. C. Jeanny, Y. Courtois et al., Involvement of DNase II in Nuclear Degeneration during Lens Cell Differentiation, Journal of Biological Chemistry, vol.270, issue.48, pp.28579-85, 1995.
DOI : 10.1074/jbc.270.48.28579

URL : https://hal.archives-ouvertes.fr/inserm-00769967

C. Blenn, F. R. Althaus, and M. Malanga, -induced cell death, Biochemical Journal, vol.396, issue.3, pp.419-448, 2006.
DOI : 10.1042/BJ20051696

P. Szurman, Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo, Experimental Eye Research, vol.85, issue.1, pp.44-53, 2007.
DOI : 10.1016/j.exer.2007.03.003

I. Tanida, T. Ueno, and E. Kominami, LC3 conjugation system in mammalian autophagy, The International Journal of Biochemistry & Cell Biology, vol.36, issue.12, pp.2503-2521, 2004.
DOI : 10.1016/j.biocel.2004.05.009

L. Padron-barthe, C. Lepretre, E. Martin, M. F. Counis, and A. Torriglia, Conformational Modification of Serpins Transforms Leukocyte Elastase Inhibitor into an Endonuclease Involved in Apoptosis, Molecular and Cellular Biology, vol.27, issue.11, pp.4028-4064, 2007.
DOI : 10.1128/MCB.01959-06

URL : https://hal.archives-ouvertes.fr/inserm-00140748

C. A. Belmokhtar, A. Torriglia, M. F. Counis, Y. Courtois, A. Jacquemin-sablon et al., Nuclear Translocation of a Leukocyte Elastase Inhibitor/Elastase Complex during Staurosporine-Induced Apoptosis: Role in the Generation of Nuclear L-DNase II Activity, Experimental Cell Research, vol.254, issue.1, pp.99-109, 2000.
DOI : 10.1006/excr.1999.4737

A. K. Denniston, Endogenous Cortisol and TGF-?? in Human Aqueous Humor Contribute to Ocular Immune Privilege by Regulating Dendritic Cell Function, The Journal of Immunology, vol.186, issue.1, pp.305-316, 2011.
DOI : 10.4049/jimmunol.1001450

W. Chen, J. Y. Lee, and W. C. Hsieh, Effects of dexamethasone and sex hormones on cytokine-induced cellular adhesion molecule expression in human endothelial cells, Eur J Dermatol, vol.12, pp.445-453, 2002.

T. Kirsch, M. Beese, K. Wyss, U. Klinge, H. Haller et al., Aldosterone Modulates Endothelial Permeability and Endothelial Nitric Oxide Synthase Activity by Rearrangement of the Actin Cytoskeleton, Hypertension, vol.61, issue.2, pp.501-509, 2013.
DOI : 10.1161/HYPERTENSIONAHA.111.196832

M. Luke, The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina, Experimental Eye Research, vol.87, issue.1, pp.22-31, 2008.
DOI : 10.1016/j.exer.2008.04.005

F. Valamanesh, A. Torriglia, M. Savoldelli, C. Gandolphe, J. C. Jeanny et al., Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis, Mol Vis, vol.13, pp.1746-57, 2007.

. Mccuen, B. M. Bw-2nd, Y. Tano, D. Chandler, and R. Machemer, The Lack of Toxicity of Intravitreally Administered Triamcinolone Acetonide, American Journal of Ophthalmology, vol.91, issue.6, pp.785-788, 1981.
DOI : 10.1016/0002-9394(81)90013-1

R. Narayanan, J. K. Mungcal, M. C. Kenney, G. M. Seigel, and B. D. Kuppermann, Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells, Investigative Opthalmology & Visual Science, vol.47, issue.2, pp.722-730, 2006.
DOI : 10.1167/iovs.05-0772

V. L. Morrison, H. J. Koh, L. Cheng, K. Bessho, M. C. Davidson et al., INTRAVITREAL TOXICITY OF THE KENALOG VEHICLE (BENZYL ALCOHOL) IN RABBITS, Retina, vol.26, issue.3, pp.339-383, 2006.
DOI : 10.1097/00006982-200603000-00014

C. K. Yeung, K. P. Chan, S. W. Chiang, C. P. Pang, and D. S. Lam, The Toxic and Stress Responses of Cultured Human Retinal Pigment Epithelium (ARPE19) and Human Glial Cells (SVG) in the Presence of Triamcinolone, Investigative Opthalmology & Visual Science, vol.44, issue.12, pp.5293-300, 2003.
DOI : 10.1167/iovs.03-0490

D. Smet, M. Taylor, S. Bodaghi, B. Miserocchi, E. Murray et al., Understanding uveitis: The impact of research on visual outcomes, Progress in Retinal and Eye Research, vol.30, issue.6, pp.452-470, 2011.
DOI : 10.1016/j.preteyeres.2011.06.005

K. Mercieca and N. Jones, Treatment of acute anterior uveitis in the community, as seen in an emergency eye centre. A lesson for the general practitioner?, European Journal of General Practice, vol.49, issue.1, pp.26-35, 2012.
DOI : 10.3109/13814788.2011.618221

O. Lima, . Jr, G. Passos, and J. Calixto, Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis, Mol Pharmacol, vol.74, pp.154-161, 2008.

S. Taylor, H. Isa, L. Joshi, and S. Lightman, New Developments in Corticosteroid Therapy for Uveitis, Ophthalmologica, vol.224, issue.1, pp.46-53, 2010.
DOI : 10.1159/000318021

R. Agrawal, S. Murthy, V. Sangwan, and J. Biswas, Current approach in diagnosis and management of anterior uveitis, Indian Journal of Ophthalmology, vol.58, issue.1, pp.11-19, 2010.
DOI : 10.4103/0301-4738.58468

S. Abad, P. Sève, R. Dhote, and A. Brézin, Uvéites et médecine interne Stratégiesdiagnostique et thérapeutique. La Revue de médecine interne, pp.492-500, 2009.

D. Smet and M. , Corticosteroid Intravitreal Implants, Dev Ophthalmol, vol.51, pp.122-133, 2012.
DOI : 10.1159/000336330

M. Tsai, C. Horng, S. Chen, X. Xiao, C. Wang et al., Suppression of experimental uveitis by a recombinant adenoassociated virus vector encoding interleukin-1 receptor antagonist, Molecular Vision, vol.15, pp.1542-1552, 2009.

Z. Han, D. Boyle, K. Aupperle, B. Bennett, A. Manning et al., Jun N-terminal kinase in rheumatoid arthritis, J Pharmacol Exp Ther, vol.291, issue.1, pp.124-130, 1999.

. Sb, Activation of stress-activated protein kinase in osteoarthritic cartilage. Evidencefor nitric oxide dependence, Osteoarthritis Cartilage, vol.9, issue.4, pp.294-299, 2001.

L. Hirt, J. Badaut, J. Thevenet, C. Granziera, L. Regli et al., D-JNKI1, a Cell-Penetrating c-Jun-N-Terminal Kinase Inhibitor, Protects Against Cell Death in Severe Cerebral Ischemia, Stroke, vol.35, issue.7, pp.1738-1743, 2004.
DOI : 10.1161/01.STR.0000131480.03994.b1

P. Crisanti, D. Kozak, Y. Combette, J. Behar-cohen, and F. , A peptide inhibitor of c-jun Nterminal kinase for the treatment of endotoxin-induced uveitis, Invest Ophthalmol Vis Sc, vol.51, pp.4683-4693, 2010.

J. Rosenbaum, H. Mcdevitt, R. Guss, and E. R. , Endotoxin-induced uveitis in rats as a model for human disease, Nature, vol.84, issue.5773, pp.611-613, 1980.
DOI : 10.1038/286611a0

M. Hashida, A. Fukushima, J. Zhang, H. Kodama, and H. Ueno, Involvement of superoxide generated by polymorphonuclear leukocytes in endotoxin-induced uveitis, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.238, issue.4, pp.359-365, 2000.
DOI : 10.1007/s004170050365

F. Behar-cohen, J. Parel, Y. Pouliquen, B. Thillaye-goldenberg, O. Goureau et al., Iontophoresis of Dexamethasone in the Treatment of Endotoxin-Induced-Uveitis in Rats, Experimental Eye Research, vol.65, issue.4, pp.533-545, 1997.
DOI : 10.1006/exer.1997.0364

Y. Ip and D. , Signal transduction by the c-Jun N-terminal kinase (JNK) ??? from inflammation to development, Current Opinion in Cell Biology, vol.10, issue.2, pp.205-219, 1998.
DOI : 10.1016/S0955-0674(98)80143-9

Z. Chi, S. Hayasaka, X. Zhang, H. Cui, and Y. Hayasaka, A Cholinergic Agonist Attenuates Endotoxin-Induced Uveitis in Rats, Investigative Opthalmology & Visual Science, vol.48, issue.6, pp.2719-2725, 2007.
DOI : 10.1167/iovs.06-0644

K. Reinecke, S. Eminel, F. Dierck, W. Roessner, S. Kersting et al., The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis, PLoS ONE, vol.98, issue.3, p.30985, 2012.
DOI : 10.1371/journal.pone.0030985.t001

C. Bonny, A. Oberson, S. Negri, C. Sauser, and D. Schorderet, Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of ??-Cell Death, Diabetes, vol.50, issue.1, pp.77-82, 2001.
DOI : 10.2337/diabetes.50.1.77

O. Weijtens, E. Feron, R. Schoemaker, A. Cohen, E. Lentjes et al., High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection, American Journal of Ophthalmology, vol.128, issue.2, pp.192-197, 1999.
DOI : 10.1016/S0002-9394(99)00129-4

O. Weijtens, R. Schoemaker, A. Cohen, F. Romijn, E. Lentjes et al., Dexamethasone Concentration in Vitreous and Serum After Oral Administration, American Journal of Ophthalmology, vol.125, issue.5, pp.673-679, 1998.
DOI : 10.1016/S0002-9394(98)00003-8

O. Weijtens, F. Van-der-sluijs, R. Schoemaker, E. Lentjes, A. Cohen et al., Peribulbar Corticosteroid Injection: Vitreal and Serum Concentrations After Dexamethasone Disodium Phosphate Injection, American Journal of Ophthalmology, vol.123, issue.3, pp.358-363, 1997.
DOI : 10.1016/S0002-9394(14)70131-X

B. 1. Xing, Y. Parker, C. R. Edwards, M. Rainey, and W. E. , ACTH is a potent regulator of gene expression in human adrenal cells, Journal of Molecular Endocrinology, vol.45, issue.1, pp.59-68, 2010.
DOI : 10.1677/JME-10-0006

F. G. Young, Thomas Addison and the Background to Cortisone, BMJ, vol.2, issue.4747, pp.1535-1541, 1951.
DOI : 10.1136/bmj.2.4747.1535

P. S. Hench, E. C. Kendall, C. H. Slocumb, and H. F. Polley, Cortisone, its effects on rheumatoid arthritis, rheumatic fever, and certain other conditions, Merck Rep, vol.59, pp.9-14, 1950.

F. Chast, Histoire de la corticoth??rapie, La Revue de M??decine Interne, vol.34, issue.5, pp.258-263, 2013.
DOI : 10.1016/j.revmed.2012.12.009

F. Chast, Histoire contemporaine des médicaments, 2002.

R. Voutilainen, J. Tapanainen, B. C. Chung, K. J. Matteson, and W. L. Miller, Hormonal regulation of P450scc, J Clin Endocrinol Metab, vol.201717, issue.63, pp.22-450, 1986.

M. Zhao, F. Valamanesh, I. Celerier, M. Savoldelli, L. Jonet et al., The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells, The FASEB Journal, vol.24, issue.9, pp.3405-3415, 2010.
DOI : 10.1096/fj.09-154344

S. Rivest, How circulating cytokines trigger the neural circuits that control the hypothalamic???pituitary???adrenal axis, Psychoneuroendocrinology, vol.26, issue.8, pp.761-788, 2001.
DOI : 10.1016/S0306-4530(01)00064-6

E. A. Slavinski, J. W. Jull, and N. Auersperg, STEROIDOGENIC PATHWAYS AND TROPHIC RESPONSE TO ADRENOCORTICOTROPHIN OF CULTURED ADRENOCORTICAL CELLS IN DIFFERENT STATES OF DIFFERENTIATION, Journal of Endocrinology, vol.69, issue.3, pp.385-394, 1976.
DOI : 10.1677/joe.0.0690385

D. M. Stocco, StAR Protein and the Regulation of Steroid Hormone Biosynthesis, Annual Review of Physiology, vol.63, issue.1, pp.193-213, 2001.
DOI : 10.1146/annurev.physiol.63.1.193

G. P. Chrousos, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation, N Engl J Med, vol.332, pp.1351-1362, 1995.

D. Jezova, T. Ochedalski, A. Kiss, and G. Aguilera, Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress receptor phosphorylation in a model of oxygen-induced retinopathy, J Neuroendocrinol Invest Ophthalmol Vis Sci, vol.10, issue.47, pp.67-72, 1998.

P. Szurman, A. Sierra, R. Kaczmarek, G. B. Jaissle, B. Wallenfels-thilo et al., Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo, Experimental Eye Research, vol.85, issue.1, pp.44-53, 2007.
DOI : 10.1016/j.exer.2007.03.003

J. Folkman and D. E. Ingber, Angiostatic Steroids, Annals of Surgery, vol.206, issue.3, pp.374-383, 1987.
DOI : 10.1097/00000658-198709000-00016

A. Katychev, X. Wang, A. Duffy, D. , and P. , Glucocorticoid-Induced Apoptosis in CNS Microvascular Pericytes, Developmental Neuroscience, vol.25, issue.6, pp.436-446, 2003.
DOI : 10.1159/000075669

Z. M. Hu, H. B. Wang, M. Q. Zhou, X. S. Yao, L. Ma et al., [Pathological changes of the blood vessels in rabbit femoral head with glucocorticoidinduced necrosis], pp.785-787, 2006.

R. A. Lockshin, W. , and C. M. , Programmed cell death???V. Cytolytic enzymes in relation to the breakdown of the intersegmental muscles of silkmoths, Journal of Insect Physiology, vol.11, issue.7, pp.831-844, 1965.
DOI : 10.1016/0022-1910(65)90186-1

J. B. Stevens, B. Y. Abdallah, G. Liu, S. D. Horne, S. W. Bremer et al., Heterogeneity of Cell Death, Cytogenetic and Genome Research, vol.139, issue.3, pp.164-173, 2013.
DOI : 10.1159/000348679

G. Kroemer, M. , and S. J. , Caspase-independent cell death, Nature Medicine, vol.12, issue.7, pp.725-730, 2005.
DOI : 10.1038/sj.jcbfm.9600080

M. Jaattela and J. Tschopp, Caspase-independent cell death in T lymphocytes, Nature Immunology, vol.4, issue.5, pp.416-423, 2003.
DOI : 10.1038/ni0503-416

L. Cherlonneix, Recherches sur l'auto-initiation de la Mort cellulaire à la fin du XIXe siècle, In Gesnerus, vol.64, pp.193-218, 2007.

A. Glucksmann, Cell death in normal development, Archives de Biologie, vol.76, pp.419-437, 1965.

J. F. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, British Journal of Cancer, vol.26, issue.4, pp.239-257, 1972.
DOI : 10.1038/bjc.1972.33

L. Galluzzi, I. Vitale, J. M. Abrams, E. S. Alnemri, E. H. Baehrecke et al., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, and Kroemer, G. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, pp.107-120
DOI : 10.1083/jcb.200712051

G. Kroemer, L. Galluzzi, P. Vandenabeele, J. Abrams, E. S. Alnemri et al., Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009, Cell Death and Differentiation, vol.4, issue.1, pp.3-11, 2009.
DOI : 10.1242/dev.00933

URL : https://hal.archives-ouvertes.fr/hal-00407686

V. Giansanti, A. Torriglia, and A. I. Scovassi, Conversation between apoptosis and autophagy: ???Is it your turn or mine????, Apoptosis, vol.11, issue.4, pp.321-333, 2011.
DOI : 10.1007/s10495-011-0589-x

J. Yuan, M. Lipinski, and A. Degterev, Diversity in the Mechanisms of Neuronal Cell Death, Neuron, vol.40, issue.2, pp.401-413, 2003.
DOI : 10.1016/S0896-6273(03)00601-9

I. Nishino, Autophagic vacuolar myopathies, Current Neurology and Neuroscience Reports, vol.57, issue.1, pp.64-69, 2003.
DOI : 10.1007/s11910-003-0040-y

S. Fulda, Autophagy and cell death, Autophagy, vol.8, issue.8, pp.1250-1251, 2012.
DOI : 10.4161/auto.20669

P. Boya, R. A. Gonzalez-polo, N. Casares, J. L. Perfettini, P. Dessen et al., Inhibition of Macroautophagy Triggers Apoptosis, Molecular and Cellular Biology, vol.25, issue.3, pp.1025-1040, 2005.
DOI : 10.1128/MCB.25.3.1025-1040.2005

M. J. Abedin, D. Wang, M. A. Mcdonnell, U. Lehmann, and A. Kelekar, Autophagy delays apoptotic death in breast cancer cells following DNA damage, Cell Death and Differentiation, vol.109, issue.3, pp.500-510, 2007.
DOI : 10.1093/emboj/18.9.2330

V. Giansanti, G. E. Rodriguez, M. Savoldelli, R. Gioia, A. Forlino et al., Characterization of stress response in human retinal epithelial cells, Journal of Cellular and Molecular Medicine, vol.6, issue.1, pp.103-115, 2013.
DOI : 10.1111/j.1582-4934.2012.01652.x

M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu et al., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature, vol.391, pp.43-50, 1998.

A. Yoshida, Y. Pommier, and T. Ueda, Endonuclease Activation and Chromosomal DNA Fragmentation during Apoptosis in Leukemia Cells, International Journal of Hematology, vol.156, issue.1, pp.31-37, 2006.
DOI : 10.1007/BF03342699

K. Samejima and W. C. Earnshaw, Trashing the genome: the role of nucleases during apoptosis, Nature Reviews Molecular Cell Biology, vol.18, issue.9, pp.677-688, 2005.
DOI : 10.1038/nrm1715

H. Li, H. Zhu, C. J. Xu, and J. Yuan, Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis, Cell, vol.94, issue.4, pp.491-501, 1998.
DOI : 10.1016/S0092-8674(00)81590-1

X. Luo, I. Budihardjo, H. Zou, C. Slaughter, W. et al., Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors, Cell, vol.94, issue.4, pp.481-490, 1998.
DOI : 10.1016/S0092-8674(00)81589-5

L. Virag, A. Robaszkiewicz, J. M. Vargas, J. Oliver, and F. , Poly(ADPribose ) signaling in cell death, 2013.

D. 'amours, D. Sallmann, F. R. Dixit, V. M. Poirier, and G. G. , Gain-offunction of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis, J Cell Sci, vol.114, pp.3771-3778, 2001.

M. Germain, E. B. Affar, D. D-'amours, V. M. Dixit, G. S. Salvesen et al., Cleavage of Automodified Poly(ADP-ribose) Polymerase during Apoptosis: EVIDENCE FOR INVOLVEMENT OF CASPASE-7, Journal of Biological Chemistry, vol.274, issue.40, pp.28379-28384, 1999.
DOI : 10.1074/jbc.274.40.28379

D. 'amours, D. Germain, M. Orth, K. Dixit, V. M. Poirier et al., Proteolysis of Poly(ADP-Ribose) Polymerase by Caspase 3: Kinetics of Cleavage of Mono(ADP-Ribosyl)ated and DNA-Bound Substrates, Radiation Research, vol.150, issue.1, pp.3-10, 1998.
DOI : 10.2307/3579638

C. M. Simbulan-rosenthal, D. S. Rosenthal, S. Iyer, H. Boulares, and M. E. Smulson, Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication, Mol Cell Biochem, vol.193, pp.137-148, 1999.
DOI : 10.1007/978-1-4419-8740-2_20

R. Krishnakumar and W. L. Kraus, The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets, Molecular Cell, vol.39, issue.1, pp.8-24, 2010.
DOI : 10.1016/j.molcel.2010.06.017

R. J. Youle and A. Strasser, The BCL-2 protein family: opposing activities that mediate cell death, Nature Reviews Molecular Cell Biology, vol.94, issue.1, pp.47-59, 2008.
DOI : 10.1038/nrm2308

M. Giam, D. C. Huang, and P. Bouillet, BH3-only proteins and their roles in programmed cell death, Oncogene, vol.14, pp.128-136, 2008.
DOI : 10.1101/GAD.897601

M. J. Mate, M. Ortiz-lombardia, B. Boitel, A. Haouz, D. Tello et al., The crystal structure of the mouse apoptosis-inducing factor AIF, Nature Structural Biology, vol.9, issue.6, pp.442-446, 2002.
DOI : 10.1038/nsb793

E. Daugas, D. Nochy, L. Ravagnan, M. Loeffler, S. A. Susin et al., Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis, FEBS Letters, vol.401, issue.3, pp.118-123, 2000.
DOI : 10.1016/S0014-5793(00)01731-2

N. Joza, J. A. Pospisilik, E. Hangen, T. Hanada, N. Modjtahedi et al., AIF: Not Just an Apoptosis-Inducing Factor, Annals of the New York Academy of Sciences, vol.63, issue.1, pp.2-11, 2009.
DOI : 10.1111/j.1749-6632.2009.04681.x

E. Norberg, S. Orrenius, and B. Zhivotovsky, Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF), Biochemical and Biophysical Research Communications, vol.396, issue.1, pp.95-100, 2010.
DOI : 10.1016/j.bbrc.2010.02.163

C. Artus, H. Boujrad, A. Bouharrour, M. N. Brunelle, S. Hoos et al., AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX, The EMBO Journal, vol.42, issue.9, pp.1585-1599, 2010.
DOI : 10.1101/gad.1199904

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876946

H. K. Lorenzo, S. A. Susin, J. Penninger, and G. Kroemer, Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death, Cell Death and Differentiation, vol.6, issue.6, pp.516-524, 1999.
DOI : 10.1038/sj.cdd.4400527

E. Hangen, K. Blomgren, P. Benit, G. Kroemer, and N. Modjtahedi, Life with or without AIF, Trends in Biochemical Sciences, vol.35, issue.5, pp.278-287, 2010.
DOI : 10.1016/j.tibs.2009.12.008

S. W. Yu, Y. Wang, D. S. Frydenlund, O. P. Ottersen, V. L. Dawson et al., Outer Mitochondrial Membrane Localization of Apoptosis-Inducing Factor: Mechanistic Implications for Release, ASN Neuro, vol.103, issue.5, 2009.
DOI : 10.1042/AN20090046

X. Yang, J. Wang, Y. Zhou, Y. Wang, S. Wang et al., Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells, Cancer Letters, vol.321, issue.2, pp.137-143, 2012.
DOI : 10.1016/j.canlet.2012.01.030

S. Choudhury, S. Bae, Q. Ke, J. Y. Lee, J. Kim et al., Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion, Basic Research in Cardiology, vol.18, issue.3, pp.397-407, 2011.
DOI : 10.1007/s00395-011-0164-1

S. A. Susin, H. K. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow et al., Molecular characterization of mitochondrial apoptosis-inducing factor, Nature, vol.397, pp.441-446, 1999.

C. Cande, N. Vahsen, I. Kouranti, E. Schmitt, E. Daugas et al., AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis, Oncogene, vol.23, issue.8, pp.1514-1521, 2004.
DOI : 10.1038/sj.onc.1207279

X. Wang, C. Yang, J. Chai, Y. Shi, and D. Xue, Mechanisms of AIF-Mediated Apoptotic DNA Degradation in Caenorhabditis elegans, Science, vol.298, issue.5598, pp.1587-1592, 2002.
DOI : 10.1126/science.1076194

C. Lepretre, G. Tchakarska, H. Blibech, C. Lebon, and A. Torriglia, Apoptosis-inducing factor (AIF) and leukocyte elastase inhibitor/l-DNase II (LEI/LDNaseII), can interact to conduct caspase-independent cell death, Apoptosis, vol.88, issue.9, pp.1048-1059, 2013.
DOI : 10.1007/s10495-013-0862-2

Y. Tan, C. Wu, D. Veyra, T. , G. et al., Ubiquitous Calpains Promote Both Apoptosis and Survival Signals in Response to Different Cell Death Stimuli, Journal of Biological Chemistry, vol.281, issue.26, pp.17689-17698, 2006.
DOI : 10.1074/jbc.M601978200

D. E. Croall and K. Ersfeld, The calpains: modular designs and functional diversity, Genome Biology, vol.8, issue.6, p.218, 2007.
DOI : 10.1186/gb-2007-8-6-218

C. Tardy, P. Codogno, H. Autefage, T. Levade, and N. Andrieu-abadie, Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle), Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1765, issue.2, pp.101-125, 2006.
DOI : 10.1016/j.bbcan.2005.11.003

URL : https://hal.archives-ouvertes.fr/inserm-00172288

G. Kroemer and M. Jaattela, Lysosomes and autophagy in cell death control, Nature Reviews Cancer, vol.24, issue.11, pp.886-897, 2005.
DOI : 10.1016/S0092-8674(01)00421-4

V. Rodriguez, G. E. Torriglia, and A. , Calpain 1 induce lysosomal permeabilization by cleavage of lysosomal associated membrane protein 2, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1833, issue.10, pp.2244-2253, 2013.
DOI : 10.1016/j.bbamcr.2013.05.019

S. Chahory, N. Keller, E. Martin, B. Omri, P. Crisanti et al., Light induced retinal degeneration activates a caspase-independent pathway involving cathepsin D, Neurochemistry International, vol.57, issue.3, pp.278-287, 2010.
DOI : 10.1016/j.neuint.2010.06.006

S. Chahory, L. Padron, Y. Courtois, and A. Torriglia, The LEI/L-DNase II pathway is activated in light-induced retinal degeneration in rats, Neuroscience Letters, vol.367, issue.2, pp.205-209, 2004.
DOI : 10.1016/j.neulet.2004.06.004

URL : https://hal.archives-ouvertes.fr/inserm-00143906

J. A. Trapani, Granzymes, Genome Biol, vol.2, p.3014, 2001.
DOI : 10.1006/rwei.1999.0266

M. F. Counis and A. Torriglia, DNases and apoptosis, Biochemistry and Cell Biology, vol.78, issue.4, pp.405-414, 2000.
DOI : 10.1139/o00-051

URL : https://hal.archives-ouvertes.fr/inserm-00129402

A. Torriglia, P. Perani, J. Y. Brossas, E. Chaudun, J. Treton et al., L-DNase II, a Molecule That Links Proteases and Endonucleases in Apoptosis, Derives from the Ubiquitous Serpin Leukocyte Elastase Inhibitor, Molecular and Cellular Biology, vol.18, issue.6, pp.3612-3619, 1998.
DOI : 10.1128/MCB.18.6.3612

A. Dubin, J. Travis, J. J. Enghild, and J. Potempa, Equine leukocyte elastase inhibitor. Primary structure and identification as a thymosin-binding protein, J Biol Chem, vol.267, pp.6576-6583, 1992.

K. Izuhara, S. Ohta, S. Kanaji, H. Shiraishi, and K. Arima, Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family, Cellular and Molecular Life Sciences, vol.65, issue.16, pp.2541-2553, 2008.
DOI : 10.1007/s00018-008-8049-7

G. A. Silverman, J. C. Whisstock, D. J. Askew, S. C. Pak, C. J. Luke et al., Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis, Cellular and Molecular Life Sciences (CMLS), vol.61, issue.3, pp.301-325, 2004.
DOI : 10.1007/s00018-003-3240-3

L. Padron-barthe, C. Lepretre, E. Martin, M. F. Counis, and A. Torriglia, Conformational Modification of Serpins Transforms Leukocyte Elastase Inhibitor into an Endonuclease Involved in Apoptosis, Molecular and Cellular Biology, vol.27, issue.11, pp.4028-4036, 2007.
DOI : 10.1128/MCB.01959-06

URL : https://hal.archives-ouvertes.fr/inserm-00140748

L. Padron-barthe, J. Courta, C. Lepretre, A. Nagbou, and A. Torriglia, Leukocyte Elastase Inhibitor, the precursor of L-DNase II, inhibits apoptosis by interfering with caspase-8 activation, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1783, issue.10, pp.1755-1766, 2008.
DOI : 10.1016/j.bbamcr.2008.06.018

M. G. Grutter, Proteinase inhibitors: another new fold, Structure, vol.2, issue.7, pp.575-576, 1994.
DOI : 10.1016/S0969-2126(00)00059-9

J. Potempa, E. Korzus, T. , and J. , The serpin superfamily of proteinase inhibitors: structure, function, and regulation, J Biol Chem, vol.269, pp.15957-15960, 1994.

E. M. Springhetti, N. E. Istomina, J. C. Whisstock, T. Nikitina, C. L. Woodcock et al., Role of the M-loop and Reactive Center Loop Domains in the Folding and Bridging of Nucleosome Arrays by MENT, Journal of Biological Chemistry, vol.278, issue.44, pp.43384-43393, 2003.
DOI : 10.1074/jbc.M307635200

K. Latha, W. Zhang, N. Cella, H. Y. Shi, and M. Zhang, Maspin Mediates Increased Tumor Cell Apoptosis upon Induction of the Mitochondrial Permeability Transition, Molecular and Cellular Biology, vol.25, issue.5, pp.1737-1748, 2005.
DOI : 10.1128/MCB.25.5.1737-1748.2005

B. Gooptu and D. A. Lomas, Conformational Pathology of the Serpins: Themes, Variations, and Therapeutic Strategies, Annual Review of Biochemistry, vol.78, issue.1, pp.147-176, 2009.
DOI : 10.1146/annurev.biochem.78.082107.133320

A. Torriglia, E. Chaudun, Y. Courtois, and M. F. Counis, On the use of Zn2+ to discriminate endonucleases activated during apoptosis, Biochimie, vol.79, issue.7, pp.435-438, 1997.
DOI : 10.1016/S0300-9084(97)86153-6

URL : https://hal.archives-ouvertes.fr/inserm-00770541

C. Lepretre, Y. Fleurier, E. Martin, and A. Torriglia, Nuclear export of LEI/L-DNase II by Crm1 is essential for cell survival, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1783, issue.6, pp.1068-1075, 2008.
DOI : 10.1016/j.bbamcr.2008.02.012

A. Torriglia, E. Chaudun, F. Chany-fournier, J. C. Jeanny, Y. Courtois et al., Involvement of DNase II in Nuclear Degeneration during Lens Cell Differentiation, Journal of Biological Chemistry, vol.270, issue.48, pp.28579-28585, 1995.
DOI : 10.1074/jbc.270.48.28579

URL : https://hal.archives-ouvertes.fr/inserm-00769967

A. Torriglia, E. Chaudun, F. Chany-fournier, Y. Courtois, and M. F. Counis, Involvement of L-DNase II in Nuclear Degeneration during Chick Retina Development, Experimental Eye Research, vol.72, issue.4, pp.443-453, 2001.
DOI : 10.1006/exer.2000.0969

A. Torriglia, C. Negri, E. Chaudun, E. Prosperi, Y. Courtois et al., Differential involvement of DNases in HeLa cell apoptosis induced by etoposide and long term-culture, Cell Death and Differentiation, vol.6, issue.3, pp.234-244, 1999.
DOI : 10.1038/sj.cdd.4400486

C. Gorrini, M. Donzelli, A. Torriglia, R. Supino, O. Brison et al., Effect of apoptogenic stimuli on colon carcinoma cell lines with a different c-myc expression level, International Journal of Molecular Medicine, vol.11, pp.737-742, 2003.
DOI : 10.3892/ijmm.11.6.737

S. Altairac, S. Zeggai, P. Perani, Y. Courtois, and A. Torriglia, Apoptosis induced by Na+/H+ antiport inhibition activates the LEI/L-DNase II pathway, Cell Death and Differentiation, vol.10, issue.5, pp.548-557, 2003.
DOI : 10.1038/sj.cdd.4401195

C. A. Belmokhtar, A. Torriglia, M. F. Counis, Y. Courtois, A. Jacquemin-sablon et al., Nuclear Translocation of a Leukocyte Elastase Inhibitor/Elastase Complex during Staurosporine-Induced Apoptosis: Role in the Generation of Nuclear L-DNase II Activity, Experimental Cell Research, vol.254, issue.1, pp.99-109, 2000.
DOI : 10.1006/excr.1999.4737

J. Y. Brossas, R. Tanguy, F. Brignole-baudouin, Y. Courtois, A. Torriglia et al., L-DNase II associated with active process during ethanol induced cell death in ARPE-19, Mol Vis, vol.10, pp.65-73, 2004.

L. Galluzzi, O. Kepp, and G. Kroemer, TP53 and MTOR crosstalk to regulate cellular senescence, Aging, vol.2, issue.9, pp.535-537, 2010.
DOI : 10.18632/aging.100202

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984599

M. Hausmann, K. Leucht, C. Ploner, S. Kiessling, A. Villunger et al., BCL-2 Modifying Factor (BMF) Is a Central Regulator of Anoikis in Human Intestinal Epithelial Cells, Journal of Biological Chemistry, vol.286, issue.30, pp.26533-26540, 2011.
DOI : 10.1074/jbc.M111.265322

M. Krajcovic and M. Overholtzer, Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism, Cancer research 72, pp.1596-1601, 2012.

Y. Wang, V. L. Dawson, D. , and T. M. , Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos, Experimental Neurology, vol.218, issue.2, pp.193-202, 2009.
DOI : 10.1016/j.expneurol.2009.03.020

K. K. David, S. A. Andrabi, T. M. Dawson, D. , and V. L. , Parthanatos, a messenger of death, Frontiers in Bioscience, vol.Volume, issue.14, pp.1116-1128, 2009.
DOI : 10.2741/3297

Q. Remijsen, T. Kuijpers, E. Wirawan, S. Lippens, P. Vandenabeele et al., Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality, Cell Death and Differentiation, vol.73, issue.4, pp.581-588, 2011.
DOI : 10.1038/cdd.2011.1

E. Candi, R. Schmidt, and G. Melino, The cornified envelope: a model of cell death in the skin, Nature Reviews Molecular Cell Biology, vol.1529, issue.4, pp.328-340, 2005.
DOI : 10.1038/nrm1619

M. A. Cunningham, J. L. Edelman, and S. Kaushal, Intravitreal Steroids for Macular Edema: The Past, the Present, and the Future, Survey of Ophthalmology, vol.53, issue.2, pp.139-149, 2008.
DOI : 10.1016/j.survophthal.2007.12.005

F. Valamanesh, A. Torriglia, M. Savoldelli, C. Gandolphe, J. C. Jeanny et al., Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis, Mol Vis, vol.13, pp.1746-1757, 2007.

R. A. Samarasinghe, S. F. Witchell, and D. B. Defranco, Cooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling, Cell Cycle, vol.282, issue.15, pp.2819-2827, 2012.
DOI : 10.4161/cc.21018

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

U. H. Spandau, G. Sauder, U. Schubert, H. P. Hammes, J. et al., Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo, British Journal of Ophthalmology, vol.89, issue.6, pp.745-747, 2005.
DOI : 10.1136/bjo.2004.052563

U. H. Spandau, M. Derse, P. Schmitz-valckenberg, C. Papoulis, B. U. Sagstetter et al., Triamcinolone acetonide concentration after filtration of the solvent agent, American Journal of Ophthalmology, vol.139, issue.4, pp.712-713, 2005.
DOI : 10.1016/j.ajo.2004.09.059

J. Ashish, R. Muralidhar, P. Vijayalakshmi, and S. Meenakshi, Freeman???Sheldon syndrome: case report and review of the literature, International Ophthalmology, vol.7, issue.4, pp.405-407, 2011.
DOI : 10.1007/s10792-011-9467-3

Y. S. Chang, C. F. Lin, C. L. Wu, P. Y. Kuo, F. S. Wu et al., Mechanisms Underlying Benzyl Alcohol Cytotoxicity (Triamcinolone Acetonide Preservative) in Human Retinal Pigment Epithelial Cells, Investigative Opthalmology & Visual Science, vol.52, issue.7, pp.4214-4222, 2011.
DOI : 10.1167/iovs.10-6058

W. Kai, J. Yanrong, and L. Xiaoxin, Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.44, issue.12, pp.1152-1159, 2006.
DOI : 10.1007/s00417-005-0251-9

G. , E. Haussy, B. Collette, M. Bricq, S. Chauvet et al., Mesures et analyses biomécaniques des interactions macrocirculation/microcirculation sanguines, 20ème Congrès Français de Mécanique, pp.28-30, 2011.

P. Stewart and U. Tuor, Blood-eye barriers in the rat: Correlation of ultrastructure with function, The Journal of Comparative Neurology, vol.44, issue.4, pp.566-576, 1994.
DOI : 10.1002/cne.903400409

D. De-backer, Interactions between macrocirculation and microcirculation in shock, R??animation, vol.15, issue.2, pp.191-195, 2013.
DOI : 10.1007/s13546-013-0663-1

M. M. Lavail, K. Unoki, D. Yasumura, M. T. Matthes, G. D. Yancopoulos et al., Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light., Proceedings of the National Academy of Sciences, pp.11249-11253, 1992.
DOI : 10.1073/pnas.89.23.11249

A. K. Denniston, S. H. Kottoor, I. Khan, K. Oswal, G. P. Williams et al., Endogenous Cortisol and TGF-?? in Human Aqueous Humor Contribute to Ocular Immune Privilege by Regulating Dendritic Cell Function, The Journal of Immunology, vol.186, issue.1, pp.305-311, 2011.
DOI : 10.4049/jimmunol.1001450

T. L. Knisely, J. Hosoi, R. Nazareno, and R. D. Granstein, The presence of biologically significant concentrations of glucocorticoids but little or no cortisol, 1994.

N. Y. Yi, J. L. Davis, J. H. Salmon, and B. C. Gilger, Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes, Veterinary Ophthalmology, vol.26, pp.15-19, 2008.
DOI : 10.1111/j.1463-5224.2008.00636.x

M. Rae, A. Mohamad, D. Price, P. W. Hadoke, B. R. Walker et al., Cortisol Inactivation by 11??-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.4, pp.1443-1450, 2009.
DOI : 10.1210/jc.2008-1879

S. Greenberger, E. Boscolo, I. Adini, J. B. Mulliken, and J. Bischoff, Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells, New England Journal of Medicine, vol.362, issue.11, pp.1005-1013, 2010.
DOI : 10.1056/NEJMoa0903036

E. Kluza, S. Y. Yeo, S. Schmid, D. W. Van-der-schaft, R. W. Boekhoven et al., Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity, Journal of Controlled Release, vol.151, issue.1, pp.10-17, 2011.
DOI : 10.1016/j.jconrel.2010.11.031

A. Yano, Y. Fujii, A. Iwai, Y. Kageyama, and K. Kihara, Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer Cells, Clinical Cancer Research, vol.12, issue.10, pp.3003-3009, 2006.
DOI : 10.1158/1078-0432.CCR-05-2085

J. Folkman, Toward an Understanding of Angiogenesis: Search and Discovery, Perspectives in Biology and Medicine, vol.29, issue.1, pp.10-36, 1985.
DOI : 10.1353/pbm.1985.0049

P. W. Hadoke, J. Iqbal, and B. R. Walker, Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease, British Journal of Pharmacology, vol.44, issue.2, pp.689-712, 2009.
DOI : 10.1111/j.1476-5381.2008.00047.x

R. S. Weinstein, Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity, Bone, vol.46, issue.3, pp.564-570, 2010.
DOI : 10.1016/j.bone.2009.06.030

A. Martidis, D. G. Miller, T. A. Ciulla, R. P. Danis, and R. S. Moorthy, Corticosteroids as an Antiangiogenic Agent for Histoplasmosis-Related Subfoveal Choroidal Neovascularization, Journal of Ocular Pharmacology and Therapeutics, vol.15, issue.5, pp.425-428, 1999.
DOI : 10.1089/jop.1999.15.425

K. E. Aziz, W. , and D. , Modulation of Endothelial Cell Expression of ICAM-1, E-Selectin, and VCAM-1 by ??-Estradiol, Progesterone, and Dexamethasone, Cellular Immunology, vol.167, issue.1, pp.79-85, 1996.
DOI : 10.1006/cimm.1996.0010

G. Vinukonda, K. Dummula, S. Malik, F. Hu, C. I. Thompson et al., Effect of Prenatal Glucocorticoids on Cerebral Vasculature of the Developing Brain * Supplemental Methods, Stroke, vol.41, issue.8, pp.1766-1773, 2010.
DOI : 10.1161/STROKEAHA.110.588400

C. Dot, F. Behar-cohen, D. Benezra, M. Doat, L. Jonet et al., Influence of triamcinolone intravitreal injection on retinochoroidal healing processes, Experimental Eye Research, vol.84, issue.6, pp.1081-1089, 2007.
DOI : 10.1016/j.exer.2007.01.024

T. L. Mckay, D. J. Gedeon, M. B. Vickerman, A. G. Hylton, D. Ribita et al., Selective Inhibition of Angiogenesis in Small Blood Vessels and Decrease in Vessel Diameter throughout the Vascular Tree by Triamcinolone Acetonide, Investigative Opthalmology & Visual Science, vol.49, issue.3, pp.1184-1190, 2008.
DOI : 10.1167/iovs.07-1329

F. Behar-cohen, Cibles r??tiniennes d???action des m??dicaments, Annales Pharmaceutiques Fran??aises, vol.69, issue.2, pp.124-130, 2011.
DOI : 10.1016/j.pharma.2011.01.003

J. T. Rosenbaum, H. O. Mcdevitt, R. B. Guss, E. , and P. R. , Endotoxin-induced uveitis in rats as a model for human disease, Nature, vol.84, issue.5773, pp.611-613, 1980.
DOI : 10.1038/286611a0

F. F. Behar-cohen, J. M. Parel, Y. Pouliquen, B. Thillaye-goldenberg, O. Goureau et al., Iontophoresis of Dexamethasone in the Treatment of Endotoxin-Induced-Uveitis in Rats, Experimental Eye Research, vol.65, issue.4, pp.533-545, 1997.
DOI : 10.1006/exer.1997.0364

A. M. Manning, D. , and R. J. , Targeting JNK for therapeutic benefit: from junk to gold?, Nature Reviews Drug Discovery, vol.2, issue.7, pp.554-565, 2003.
DOI : 10.1038/nrd1132

L. Hirt, J. Badaut, J. Thevenet, C. Granziera, L. Regli et al., D-JNKI1, a Cell-Penetrating c-Jun-N-Terminal Kinase Inhibitor, Protects Against Cell Death in Severe Cerebral Ischemia, Stroke, vol.35, issue.7, pp.1738-1743, 2004.
DOI : 10.1161/01.STR.0000131480.03994.b1

E. Touchard, L. Kowalczuk, C. Bloquel, M. C. Naud, P. Bigey et al., The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins, The Journal of Gene Medicine, vol.43, issue.11, pp.904-919, 2010.
DOI : 10.1002/jgm.1517

E. Sanharawi, M. Kowalczuk, L. Touchard, E. Omri, S. De-kozak et al., Protein delivery for retinal diseases: From basic considerations to clinical applications, Progress in retinal and eye research, pp.443-465, 2010.
DOI : 10.1016/j.preteyeres.2010.04.001

A. Thakur, R. S. Kadam, and U. B. Kompella, Influence of Drug Solubility and Lipophilicity on Transscleral Retinal Delivery of Six Corticosteroids, Drug Metabolism and Disposition, vol.39, issue.5, pp.771-781, 2011.
DOI : 10.1124/dmd.110.037408

C. Stellato, Post-transcriptional and Nongenomic Effects of Glucocorticoids, Proceedings of the American Thoracic Society, vol.1, issue.3, pp.255-263, 2004.
DOI : 10.1513/pats.200402-015MS

. Abbreviations, . Csa, A. Cyclosporine, and . Ded, dry eye disease; CLSO, confocal laser scanning ophthalmoscope; UHPLC?MS/MS, ultra high pressure liquid chromatography coupled with triple quadrupole mass spectrometer; d 12 CsA, deuterated CsA; IS, internal standard; PBS, phosphate buffer solution; CS, calibration standard; STT, Schirmer tear test

H. D. Perry, Dry eye disease: pathophysiology, classification, and diagnosis, Am. J. Manag. Care, vol.14, pp.79-87, 2008.

K. Gumus and D. H. Cavanagh, The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca, Clin. Ophthalmol, vol.3, pp.57-67, 2009.

M. E. Johnson and P. J. Murphy, Changes in the tear film and ocular surface from dry eye syndrome, Progress in Retinal and Eye Research, vol.23, issue.4, pp.449-474, 2004.
DOI : 10.1016/j.preteyeres.2004.04.003

R. M. Schiffman, J. G. Walt, G. Jacobsen, J. J. Doyle, G. Lebovics et al., Utility assessment among patients with dry eye disease, Ophthalmology, vol.110, issue.7, pp.1412-1419, 2003.
DOI : 10.1016/S0161-6420(03)00462-7

URL : http://doi.org/10.1016/s0161-6420(03)00462-7

F. Lallemand, O. Felt-baeyens, K. Besseghir, F. Behar-cohen, and R. Gurny, Cyclosporine A delivery to the eye: A pharmaceutical challenge, European Journal of Pharmaceutics and Biopharmaceutics, vol.56, issue.3, pp.56-307, 2003.
DOI : 10.1016/S0939-6411(03)00138-3

S. Kashani and A. A. Mearza, Uses and safety profile of ciclosporin in ophthalmology, Expert Opinion on Drug Safety, vol.69, issue.1, pp.79-89, 2008.
DOI : 10.1097/01.ico.0000151507.49565.6e

S. M. Stepkowski, Molecular targets for existing and novel immunosuppressive drugs, Expert Reviews in Molecular Medicine, vol.2, issue.04, pp.1-23, 2000.
DOI : 10.1017/S1462399400001769

S. Matsuda and S. Koyasu, Mechanisms of action of cyclosporine, Immunopharmacology, vol.47, issue.2-3, pp.119-125, 2000.
DOI : 10.1016/S0162-3109(00)00192-2

N. Andre, B. Roquelaure, and J. Conrath, Molecular effects of cyclosporine and oncogenesis: a new model, Medical Hypotheses, vol.63, issue.4, pp.647-652, 2004.
DOI : 10.1016/j.mehy.2004.03.030

A. Yoshida, T. Fujihara, and K. Nakata, Cyclosporin A Increases Tear Fluid Secretion via Release of Sensory Neurotransmitters and Muscarinic Pathway in Mice, Experimental Eye Research, vol.68, issue.5, pp.541-546, 1999.
DOI : 10.1006/exer.1998.0619

H. Toshida, K. Nakayasu, and A. Kanai, Effect of Cyclosporin A Eyedrops on Tear Secretion in Rabbit, Japanese Journal of Ophthalmology, vol.42, issue.3, pp.168-173, 1998.
DOI : 10.1016/S0021-5155(98)00003-3

A. G. Palestine, R. B. Nussenblatt, and C. C. Chan, Side effects of systemic cyclosporine in patients not undergoing transplantation, The American Journal of Medicine, vol.77, issue.4, pp.77-654, 1984.
DOI : 10.1016/0002-9343(84)90356-5

E. Clarke, Clarke's Isolation and Identification of Drugs, 1986.

A. R. Hamel, F. Hubler, A. Carrupt, R. M. Wenger, and M. Mutter, Cyclosporin A prodrugs: design, synthesis and biophysical properties, The Journal of Peptide Research, vol.9, issue.2, pp.63-147, 2004.
DOI : 10.1111/j.1399-3011.2003.00111.x

F. Lallemand, O. Felt-baeyens, S. Rudaz, A. R. Hamel, F. Hubler et al., Conversion of cyclosporine A prodrugs in human tears vs. rabbits tears, Eur, J. Pharm. Biopharm, pp.59-51, 2005.

F. Lallemand, P. Furrer, O. Felt-baeyens, M. Gex-fabry, J. M. Dumont et al., A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics, International Journal of Pharmaceutics, vol.295, issue.1-2, pp.295-302, 2005.
DOI : 10.1016/j.ijpharm.2004.12.015

F. Lallemand, P. Perottet, O. Felt-baeyens, W. Kloeti, F. Philippoz et al., A water-soluble prodrug of cyclosporine A for ocular application: A stability study, European Journal of Pharmaceutical Sciences, vol.26, issue.1, pp.124-129, 2005.
DOI : 10.1016/j.ejps.2005.05.003

F. Lallemand, E. Varesio, O. Felt-baeyens, L. Bossy, G. Hopfgartner et al., Biological conversion of a water-soluble prodrug of cyclosporine A, Eur, J. Pharm. Biopharm, pp.67-555, 2007.

P. Furrer, B. Plazonnet, J. M. Mayer, and R. Gurny, Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants, Int, J. Pharm, vol.207, pp.89-98, 2000.

P. Furrer and R. Gurny, Recent advances in confocal microscopy for studying drug delivery to the eye: Concepts and pharmaceutical applications, European Journal of Pharmaceutics and Biopharmaceutics, vol.74, issue.1, pp.74-107, 2010.
DOI : 10.1016/j.ejpb.2009.09.002

P. Kälin, Contribution à la validation d'un test de tolérance oculaire sur la souris, 1994.

G. Singh, R. L. Lindstrom, and D. J. Doughman, Cyclosporin A on Human Corneal Endothelium, Cornea, vol.3, issue.4, pp.272-277, 1984.
DOI : 10.1097/00003226-198404000-00008

L. Gan, Y. Gan, C. Zhu, X. Zhang, and J. Zhu, Novel microemulsion in situ electrolytetriggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results, Int. J. Pharm, pp.365-143, 2009.

D. D. Tang-liu and A. Acheampong, Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye, Clinical Pharmacokinetics, vol.18, issue.3, pp.247-261, 2005.
DOI : 10.2165/00003088-200544030-00003

]. D. Stevenson, J. Tauber, and B. L. Reis, Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease, Ophthalmology, vol.107, issue.5, pp.967-974, 2000.
DOI : 10.1016/S0161-6420(00)00035-X

P. Furrer, J. M. Mayer, B. Plazonnet, and R. Gurny, Ocular tolerance of absorption enhancers in ophthalmic preparations, AAPS PharmSci, vol.4, issue.1, p.2, 2002.
DOI : 10.1208/ps040102

C. M. Hutak and R. B. Jacaruso, Evaluation of primary ocular irritation: alternative to the Draize test Ocular Therapeutics and Drug Delivery: A Multidisciplinary Approach, pp.489-525, 1996.

L. Novakova and H. Vlckova, A review of current trends and advances in modern bio-analytical methods: Chromatography and sample preparation, Analytica Chimica Acta, vol.656, issue.1-2, pp.8-35, 2009.
DOI : 10.1016/j.aca.2009.10.004

D. Guillarme, J. Schappler, S. Rudaz, and J. L. Veuthey, Coupling ultra-high-pressure liquid chromatography with mass spectrometry, TrAC Trends in Analytical Chemistry, vol.29, issue.1, pp.29-44, 2010.
DOI : 10.1016/j.trac.2009.09.008

G. Dumortier and J. C. , Lachrymal Determinations: Methods and Updates on Biopharmaceutical and Clinical Applications, Ophthalmic Research, vol.36, issue.4, pp.183-194, 2004.
DOI : 10.1159/000078776

Y. Ohashi, M. Dogru, and K. Tsubota, Laboratory findings in tear fluid analysis, Clinica Chimica Acta, vol.369, issue.1, pp.17-28, 2006.
DOI : 10.1016/j.cca.2005.12.035

S. Barabino and M. R. Dana, Animal Models of Dry Eye: A Critical Assessment of Opportunities and Limitations, Investigative Opthalmology & Visual Science, vol.45, issue.6, pp.1641-1646, 2004.
DOI : 10.1167/iovs.03-1055

N. Worakul and J. R. Robinson, Ocular pharmacokinetics/pharmacodynamics, European Journal of Pharmaceutics and Biopharmaceutics, vol.44, issue.1, pp.71-83, 1997.
DOI : 10.1016/S0939-6411(97)00064-7

D. Benezra and G. Maftzir, Ocular Penetration of Cyclosporine A in the Rat Eye, Archives of Ophthalmology, vol.108, issue.4, pp.584-587, 1990.
DOI : 10.1001/archopht.1990.01070060132063

R. L. Kaswan, Intraocular penetration of topically applied cyclosporine, Transplant. Proc, vol.20, pp.650-655, 1988.

C. , D. Tommaso, F. Valamenesh, F. Miller, P. Furrer et al., A novel cyclosporin A aqueous formulation for dry eye treatment: in vitro and in vivo evaluation

A. Urtti, Challenges and obstacles of ocular pharmacokinetics and drug delivery, Advanced Drug Delivery Reviews, vol.58, issue.11, pp.1131-1135, 2006.
DOI : 10.1016/j.addr.2006.07.027

D. Benezra, G. Maftzir, C. De-courten, and P. Timonen, Ocular penetration of cyclosporin A. III: The human eye., British Journal of Ophthalmology, vol.74, issue.6, pp.74-350, 1990.
DOI : 10.1136/bjo.74.6.350

A. A. Acheampong, M. Shackleton, D. D. Tang-liu, S. Ding, M. E. Stern et al., Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs, Current Eye Research, vol.33, issue.7, pp.91-103, 1999.
DOI : 10.1076/ceyr.18.2.91.5381

A. Poon, M. Constantinou, E. Lamoureux, and H. R. Taylor, Topical cyclosporin a in the treatment of acute graft rejection: a randomised controlled trial, Clinical & Experimental Ophthalmology, vol.113, pp.36-415, 2008.
DOI : 10.1111/j.1442-9071.2008.01784.x

E. Mannermaa, K. S. Vellonen, and A. Urtti, Drug transport in corneal epithelium and blood???retina barrier: Emerging role of transporters in ocular pharmacokinetics, Advanced Drug Delivery Reviews, vol.58, issue.11, pp.58-1136, 2006.
DOI : 10.1016/j.addr.2006.07.024

D. Benezra and G. Maftzir, Ocular penetration of cyclosporin A. The rabbit eye, Invest. Ophthalmol. Vis. Sci, pp.31-1362, 1990.

J. Theng, L. Zhou, D. Tan, and K. W. La, Distribution of Cyclosporin A in the Cornea After Topical or Oral Administration, Journal of Ocular Pharmacology and Therapeutics, vol.18, issue.1, pp.83-88, 2002.
DOI : 10.1089/108076802317233243

M. Wiederholt, D. Kossendrup, W. Schulz, and F. Hoffmann, Pharmacokinetic of topical cyclosporin A in the rabbit eye, Invest. Ophthalmol. Vis. Sci, vol.27, pp.519-524, 1986.

M. Kuwano, H. Ibuki, N. Morikawa, A. Ota, and Y. Kawashima, Cyclosporine A formulation affects its ocular distribution in rabbits, Pharmaceutical Research, vol.19, issue.1, pp.108-111, 2002.
DOI : 10.1023/A:1013671819604

K. Sall, O. D. Stevenson, T. K. Mundorf, and B. L. Reis, Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626., Ophthalmology, vol.107, issue.4, pp.631-639, 2000.
DOI : 10.1016/S0161-6420(99)00176-1

R. A. Laibovitz, S. Solch, K. Andriano, M. O. Connell, and M. H. Silverman, Pilot Trial of Cyclosporine 1% Ophthalmic Ointment in the Treatment of Keratoconjunctivitis Sicca, Cornea, vol.12, issue.4, pp.315-323, 1993.
DOI : 10.1097/00003226-199307000-00007

A. G. Secchi, M. S. Tognon, and A. Leonardi, Topical Use of Cyclosporine in the Treatment of Vernal Keratoconjunctivitis, American Journal of Ophthalmology, vol.110, issue.6, pp.110-641, 1990.
DOI : 10.1016/S0002-9394(14)77061-8

M. W. Belin, C. S. Bouchard, S. Frantz, and J. Chmielinska, Topical Cyclosporine in High-risk Corneal Transplants, Ophthalmology, vol.96, issue.8, pp.1144-1150, 1989.
DOI : 10.1016/S0161-6420(89)32756-4

URL : http://doi.org/10.1016/s0161-6420(89)32756-4

Y. Gavrieli, Y. Sherman, and S. A. Ben-sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, The Journal of Cell Biology, vol.119, issue.3, pp.493-501, 1992.
DOI : 10.1083/jcb.119.3.493

K. Samejima and W. C. Earnshaw, Trashing the genome: the role of nucleases during apoptosis, Nature Reviews Molecular Cell Biology, vol.18, issue.9, pp.677-688, 2005.
DOI : 10.1038/nrm1715

M. F. Counis and A. Torriglia, DNases and apoptosis, Biochemistry and Cell Biology, vol.78, issue.4, pp.405-414, 2000.
DOI : 10.1139/o00-051

URL : https://hal.archives-ouvertes.fr/inserm-00129402

A. Torriglia, P. Perani, J. Y. Brossas, E. Chaudun, J. Treton et al., L-DNase II, a molecule that links proteases and endonucleases in apoptosis, derives from the ubiquitous serpin leukocyte elastase inhibitor, Mol Cell Biol, pp.18-3612, 1998.

L. Padron-barthe, C. Lepretre, E. Martin, M. F. Counis, and A. Torriglia, Conformational Modification of Serpins Transforms Leukocyte Elastase Inhibitor into an Endonuclease Involved in Apoptosis, Molecular and Cellular Biology, vol.27, issue.11, pp.27-4028, 2007.
DOI : 10.1128/MCB.01959-06

URL : https://hal.archives-ouvertes.fr/inserm-00140748

A. I. Scovassi and A. Torriglia, Activation of DNA-degrading enzymes during apoptosis, European Journal of Histochemistry, vol.47, issue.3, pp.47-185, 2003.
DOI : 10.4081/826

F. Valamanesh, A. Torriglia, M. Savoldelli, C. Gandolphe, J. C. Jeanny et al., Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis, Mol Vis, pp.13-1746, 2007.